Prevention
Abbreviations
ACH
air changes per hour
AMR
antimicrobial resistance
CI
confidence interval
DOI
declaration of interest
DR-TB
References
- Houben RMGJ, Dodd PJ. The Global Burden of Latent Tuberculosis Infection: a re-estimation using mathematical modelling. PLOS Med. 2016 :e1002152.doi:10.1371/journal.pmed.1002152.
- Cohen A, Mathiasen VD, Schön T, Wejse C. The global prevalence of latent tuberculosis: a systematic review and meta-analysis. Eur Respir J . 2019 ;54(3):1900655. doi:10.1183/13993003.00655-2019.
- Getahun H, Matteelli A, Chaisson RE, Raviglione M. Latent mycobacterium tuberculosis Infection. New England Journal of Medicine. 2015 May 28 ;372(22):2127–35.
Annex 4. Costing considerations for PMTPT
When preparing a budget for PMTPT, for example as part of a National Strategic Plan, it is important to conduct systematic costing. The TB module of the integrated health tool for planning and costing is designed to support national strategic health planning over the medium term (1). The WHO costing guidelines for tuberculosis interventions explain how to cost TB interventions from the perspective of the providers of health services and include tools for data collection (2). Listed below are key items that require costing when developing a budget for PMTPT.
Annex 2. Messages for different stakeholders
Messages for ministries of health
Annex 5 – GRADE evidence-to-decision tables
Click here to view Annex 5
Annex 4 – GRADE evidence summary tables
Click here to view Annex 4
8. Monitoring and evaluation


8.1 The role of M&E
M&E play important roles in patient care and in assessing national programmes and the global response (Fig. 11).
Pagination
- Previous page
- Page 10
- Next page